Immune Therapeutics, Inc. 4
4 · Immune Therapeutics, Inc. · Filed Jul 6, 2016
Insider Transaction Report
Form 4
ARONSTAM PETER
CHIEF FINANCIAL OFFICER
Transactions
- Award
Warrant for Common Stock
2016-06-30+100,000→ 425,000 totalExercise: $0.17From: 2016-06-30Exp: 2021-06-29→ Common Stock (100,000 underlying)